InsidersTradesSigma
Follow the Lipigon Pharmaceuticals AB share price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares trade on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Lipigon Pharmaceuticals AB has logged 3 public disclosures. Market capitalisation: €909k. The latest transaction was filed on 27 May 2025 (Purchase). Among the most active insiders: Fredrik Lindgren. All data is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Lipigon Pharmaceuticals AB es una empresa biofarmacéutica centrada en el desarrollo de tratamientos para enfermedades metabólicas. Cotiza en la Bolsa de Estocolmo (XSTO).